Scientists Cut Amyloid Plaques by 50% in Mice With Engineered Cells

A new kind of cellular immunotherapy shows promise in preventing Alzheimer's-associated plaques from forming in the brain – and even removing some when given in advanced cases.
Working with mice, scientists at Washington University developed a specially engineered virus that genetically alters cells into "super cleaners" that remove harmful proteins in the brain.
The study's authors have shown that a single injection of their new gene therapy seemed to prevent amyloid plaque development when administered before plaques had begun to form.
Even in mice with existing amyloid plaques, one injection of the gene therapy was associated with a roughly 50 percent reduction in plaques, the researchers report.
The new method borrows from a type of cancer treatment known as chimeric antigen receptor (CAR) T cell therapy, in which scientists can genetically modify the immune system's T cells to attack cancer cells.
In the new study, researchers focused on star-shaped brain cells called astrocytes, which they engineered to hunt down the amyloid beta proteins associated with cognitive decline in Alzheimer's.
This study marks the first successful attempt at engineering astrocytes to specifically target and remove amyloid beta plaques in the brains of mice with Alzheimer's disease.

https://www.science.org/doi/10.1126/science.ads3972

Tinnitus may be linked to sleep. Here's how.

Microplastics May Be Fueling Parkinson's Disease, Scientists Warn

Plastic pollution is seeping into the Earth, into wildlife, and into our bodies, and a new research review suggests tiny microplastics and nanoplastics could be disrupting some of the brain processes associated with Parkinson's.

While Parkinson's disease is associated with a wide range of risk factors, the rise we're seeing in the number of people being diagnosed – its prevalence has doubled in the last 25 years – could be at least partly down to a rise in pollutants in the environment.
For this recent review, a team of researchers referenced more than 100 previous studies, including animal studies, laboratory experiments, and computational models, to build a compelling case linking plastics to Parkinson's.
While it's not yet clear that microplastics are directly responsible, the researchers are calling for the association to be investigated further: more data is badly needed on how these ubiquitous particles may accumulate in the body and harm human health.

"With the intensification of global plastic pollution, the potential threats posed by micro- and nanoplastics (MPs/NPs) to human health have become a major concern," write the researchers in their published paper.
MPs/NPs enter the organism through ingestion, inhalation, and skin contact, subsequently accumulating in multiple organs – particularly the brain."
Microplastics are defined as fragments smaller than 5 millimeters, while nanoplastics are smaller than a micrometer – a thousandth of a millimeter. They enter the environment in numerous ways, including dissentegration of plastic waste and the release of water used to wash synthetic clothing.
Connecting findings from previous studies, the review states we ingest plastics through our food and drink, breathe them in through the air, and even absorb them through our skin.
From there, microscopic plastic fragments make their way into our brain by crossing the blood-brain barrier or entering the nerve cells lining of our nasal cavity.
To speculate on what the plastic might do when it's in the brain, the researchers point to studies showing microplastics and nanoplastics encouraging the formation of toxic alpha-synuclein protein clumps typical of brains with Parkinson's.
The review presents evidence that plastic fragments may drive neuroinflammation, disrupt communications between the brain and the gut, and carry damaging metals into the brain – a process known as ferroptosis.
All of these types of damage have been connected to Parkinson's disease in the past.

https://www.nature.com/articles/s41531-026-01272-4